SlideShare a Scribd company logo
1 of 5
Download to read offline
asc-abstracts.org http://www.asc-abstracts.org/
ASC 2015 Searchable Abstracts
9.01 Improving Predictive Value of Trauma Scoring Through Integration of ASA-PS with ISS
D. Stewart1, C. Janowak1, H. Jung1, A. Liepert1, A. O’Rourke1, S. Agarwal1 1University Of
Wisconsin,Surgery,Madison, WI, USA
Introduction: Many methods exist for predicting mortality among adult trauma patients; however, most systems
ignore patient co-morbidity, a significant predictor of outcome, in their calculations. The American Society of
Anesthesiologists Physical Status (ASA-PS), a well-validated and easy-to-use scale, is an assessment of pre-
operative status that has been shown to accurately predict post-operative mortality. Using the ASA-PS as a marker of
cumulative patient comorbidity severity we sought to test whether we would be able to improve the predictive power
of the Injury Severity Score (ISS), the most commonly utilized trauma grading system, with respect to mortality, major
complication, and discharge disposition.
Methods: A retrospective review of a prospectively collected and internally validated database at an academic Level
I trauma center was performed for consecutive adult admissions between 2009-2013. Abbreviated Injury Scale (AIS)
was measured by region (head/neck, face, thorax, abdomen, extremities, general) and severity of injury (1 to 5). ISS
was measured by summing the squares of the three most injured regions [(AIS1)2 + (AIS2)2 + (AIS3)2]. ASA-PS
scores were assigned based on patient comorbidities and then integrated with the traditional ISS in a variety of
permutations, including adjustments of ASA-PS for patient age >70 and using individual AIS components of ISS. We
assessed these various models for predictive ability with a primary outcome of mortality and secondary outcomes of
major complications as per National Trauma Data Bank (NTDB) definitions as well as discharge disposition using
receiver operating characteristic (ROC) analysis. These were compared with the ISS.
Results: All of the ISS/ASA-PS hybrid formulas outperformed ISS alone in predictive power for mortality, major
complication, and discharge disposition. The best overall permutation, (AIS1)2+(AIS2)2+(Age-Modified ASA-PS)2,
yielded an ROC of 0.888 for mortality as compared to ISS with an ROC=0.853 (p<0.001). Similar differences were
seen for discharge disposition (Hybrid ROC=0.743; ISS ROC=0.639, p<0.001) and major complication (Hybrid
ROC=0.761; ISS ROC=0.719, p<0.001).
Conclusion: Incorporating ASA-PS into calculations of trauma scoring is both simple and more predictive of mortality,
major complication, and discharge disposition than the traditional ISS metric. Replacing ISS with this new method,
which takes patient age and comorbid condition into account through adaptation of the ASA-PS improves
prognostication of outcomes and enables care providers to prioritize resources for injured patients.
Presentation Time: Tuesday, 7:30am - 9:30am
68.18 ASA-PS is Associated With Mortality Rate Among Adult Trauma Patients
D. Stewart1, C. Janowak1, A. Liepert1, A. O’Rourke1, H. Jung1, S. Agarwal1 1University Of
Wisconsin,Surgery,Madison, WI, USA
Introduction: American Society of Anesthesiologists-Physical Status (ASA-PS) classification assesses pre-
anesthesia surgical risk. Numerous studies correlate higher ASA-PS classification with increased perioperative
mortality. As the number of comorbidities in a traumatically injured patient is correlated to mortality rate, we evaluated
if ASA-PS was an indicator of mortality risk for adult trauma patients.
Methods: Our prospectively collected and internally validated database at an academic Level I trauma center was
retrospectively reviewed for adult patients for 2009-2013. ASA-PS scores were assigned based on patient
comorbidities. Three different methods were used to reflect a lack of concordance on the consideration of patient age
in establishing ASA-PS. In all three methods, NTDB-defined comorbidities were assigned an ASA-PS value and
summed for each risk level. Patients with no comorbidities were considered PS1, while PS2 consisted of those with a
single PS2 condition. Multiple PS2 conditions were considered multi-system disease, elevating a patient’s risk to
PS3. Presence of 3+ PS3 conditions led to a PS4 classification. We then evaluated mortality rates as a primary
outcome for each ASA-PS class using receiver operating characteristic (ROC) and Pearson Chi-Square analysis.
Discharge disposition and major complications were assessed as secondary outcomes.
Results: Model 1 (ASA), considered patient age >70 as a PS2 comorbidity, yielded an ROC of 0.619 for predicting
mortality. Model 2, not including age as a factor in ASA-PS (ASA–w/o Age), produced an ROC of 0.615. Model 3,
Age-Modified ASA (AM-ASA), produced an ROC of 0.648 (p<0.001). Cross-tabulation revealed mortality rates of
2.4%, 2.4%, 4%, and 13.2%, for PS1, PS2, PS3, and PS4, respectively. ASA–w/o Age (2.4%, 2.7%, 3.9%, and
13.2%) showed a similar trend, as did AM-ASA (2.4%, 1.9%, 2.9%, 10.2%), albeit with a dip in mortality rate for PS2.
All three ASA models had two-sided p<0.001 under Pearson Chi-Square analysis of mortality rates. For discharge
disposition (ASA ROC=0.668; ASA–w/o Age ROC=0.650; AM-ASA ROC=0.693) and major complications (ASA
ROC=0.648; ASA–w/o Age ROC=0.653; AM-ASA ROC=0.641) all three models showed moderate predictive power.
Conclusion: ASA-PS classification models show an association between higher risk status and increasing mortality
rate. ASA-PS is moderately predictive of mortality, discharge disposition, and major complications per ROC analysis.
AM-ASA performed significantly better for mortality and discharge disposition, indicating that age can serve as an
adjustment to the codified system to improve accuracy in the trauma population.
Presentation Time: Thursday, 1:30pm - 3:30pm
39.07 The Surgical Apgar Score in Major Esophageal Surgery
C. F. Janowak2, L. Taylor2, J. Blasberg1, J. Maloney1, R. Macke1 1University Of Wisconsin,Division Of
Cardiothoracic Surgery,Madison, WI, USA 2University Of Wisconsin,Department Of Surgery,Madison, WI, USA
Introduction: Most postoperative assessments and triage decisions are based on subjective evaluation of a
patient’s risk factors and overall condition. The Surgical Apgar Score (SAS) is a validated prognostic tool used to
predict postoperative morbidity and mortality in a wide variety of surgical patients. The esophagectomy population is
a unique subset of surgical patients who are high risk for post-operative complication and disposition resources. An
objective prognostic metric is an appealing and efficient way to allocate limited care resources to the sickest of
postoperative patients. Although other more complex risk calculators have been developed, the SAS is a simple,
bedside usable, model that has been validated in a variety of surgical populations. We evaluated the reliability of the
SAS in a major esophageal surgery population.
Methods: A retrospective review of a prospectively collected and internally validated database of cardiothoracic
operations was performed for consecutive esophagectomies from 2009 to 2013. Basic demographics, comorbidities,
post-operative complications, and intraoperative variables were collected for all patients. The primary outcomes
studied were mortality and NSQIP-defined in-hospital major complication; secondary outcomes were prolonged length
of hospital stay (LOS) greater than 10 days and post-operative disposition. We used descriptive statistics, receiver
operating characteristics (ROC) and Pearson Chi-Square analysis to analyze primary and secondary outcome
prediction efficacy of SAS. Preoperative comorbid conditions were also analyzed for association with post-operative
outcomes prognostication using odds ratio (OR) analysis.
Results: A total of 172 consecutive esophageal resections over four years were reviewed. Overall mortality was 5
deaths (2.9%) with 4 occurring within 30 days of surgery, 1 after discharge within 30 days, and 1 after 90 days of
hospitalization. Overall SAS 9-10, n=16; SAS 7-8, n=113; SAS 5-6, n= 42; and SAS ≤ 4, n=1. Of these, 34.3% had a
major complication, 27.3% had a prolonged LOS, and 12.2% were discharged to a care facility other than home. No
significant correlation was demonstrated between complication, LOS, or discharge disposition and the SAS with
respective ROC of 0.44, 0.43, and 0.44. Of the preoperative comorbid conditions analyzed, only neoadjuvant
chemoradiation significantly increased the risk of any outcome, with an OR of 3.59 (95% CI 1.38-9.37, p < 0.01) risk
of discharge to care other than home.
Conclusion: The perioperative performance measure of the SAS does not appear to have a good ability to predict
major post-operative adverse outcomes in a major esophageal surgery population.
Presentation Time: Wednesday, 7:30am - 9:30am

More Related Content

What's hot

MANAGEMENT OF COMPLICATIONS AFTER LRP: HOW TO IMPROVE EARLY CONTINENCE AND MA...
MANAGEMENT OF COMPLICATIONS AFTER LRP: HOW TO IMPROVE EARLY CONTINENCE AND MA...MANAGEMENT OF COMPLICATIONS AFTER LRP: HOW TO IMPROVE EARLY CONTINENCE AND MA...
MANAGEMENT OF COMPLICATIONS AFTER LRP: HOW TO IMPROVE EARLY CONTINENCE AND MA...Eduard Garcia Cruz
 
Calculations of risk scores
Calculations of risk scoresCalculations of risk scores
Calculations of risk scoresClaudio Melloni
 
CTAD CSF safety Poster 10 30 13
CTAD CSF safety Poster 10 30 13CTAD CSF safety Poster 10 30 13
CTAD CSF safety Poster 10 30 13Larry Drugdoc
 
Mean platelet volume and other platelet volume indices in patients with acute...
Mean platelet volume and other platelet volume indices in patients with acute...Mean platelet volume and other platelet volume indices in patients with acute...
Mean platelet volume and other platelet volume indices in patients with acute...iosrjce
 
Antithrombotic therapy for venous thromboembolic disease
Antithrombotic therapy for venous thromboembolic diseaseAntithrombotic therapy for venous thromboembolic disease
Antithrombotic therapy for venous thromboembolic diseaseMoisés Sauñe Ferrel
 
Does homeopathic Arnica Montana reduce bruising after blepharoplasty
Does homeopathic Arnica Montana reduce bruising after blepharoplastyDoes homeopathic Arnica Montana reduce bruising after blepharoplasty
Does homeopathic Arnica Montana reduce bruising after blepharoplastyBrett Kotlus
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndromeMedicinaIngles
 
SISTEMA NERVIOSO
SISTEMA NERVIOSOSISTEMA NERVIOSO
SISTEMA NERVIOSOeglimar00
 
Trauma scoring systems
Trauma scoring systemsTrauma scoring systems
Trauma scoring systemsDr Vaziri
 
Anemia e Insuficiencia cardiaca. Manuel Méndez Bailón. Hospital Infanta Leono...
Anemia e Insuficiencia cardiaca. Manuel Méndez Bailón. Hospital Infanta Leono...Anemia e Insuficiencia cardiaca. Manuel Méndez Bailón. Hospital Infanta Leono...
Anemia e Insuficiencia cardiaca. Manuel Méndez Bailón. Hospital Infanta Leono...guest4e4e515
 

What's hot (19)

Wiedermann isicem 2013 where are we now
Wiedermann isicem 2013 where are we nowWiedermann isicem 2013 where are we now
Wiedermann isicem 2013 where are we now
 
MANAGEMENT OF COMPLICATIONS AFTER LRP: HOW TO IMPROVE EARLY CONTINENCE AND MA...
MANAGEMENT OF COMPLICATIONS AFTER LRP: HOW TO IMPROVE EARLY CONTINENCE AND MA...MANAGEMENT OF COMPLICATIONS AFTER LRP: HOW TO IMPROVE EARLY CONTINENCE AND MA...
MANAGEMENT OF COMPLICATIONS AFTER LRP: HOW TO IMPROVE EARLY CONTINENCE AND MA...
 
Schold
ScholdSchold
Schold
 
Calculations of risk scores
Calculations of risk scoresCalculations of risk scores
Calculations of risk scores
 
Trauma scoring systems
Trauma scoring systems Trauma scoring systems
Trauma scoring systems
 
Hemorrhage
HemorrhageHemorrhage
Hemorrhage
 
CoAo
CoAoCoAo
CoAo
 
The reversal of cardiology practices: interventions that were tried in vain
The reversal of cardiology practices: interventions that were tried in vainThe reversal of cardiology practices: interventions that were tried in vain
The reversal of cardiology practices: interventions that were tried in vain
 
CTAD CSF safety Poster 10 30 13
CTAD CSF safety Poster 10 30 13CTAD CSF safety Poster 10 30 13
CTAD CSF safety Poster 10 30 13
 
Mean platelet volume and other platelet volume indices in patients with acute...
Mean platelet volume and other platelet volume indices in patients with acute...Mean platelet volume and other platelet volume indices in patients with acute...
Mean platelet volume and other platelet volume indices in patients with acute...
 
Antithrombotic therapy for venous thromboembolic disease
Antithrombotic therapy for venous thromboembolic diseaseAntithrombotic therapy for venous thromboembolic disease
Antithrombotic therapy for venous thromboembolic disease
 
Does homeopathic Arnica Montana reduce bruising after blepharoplasty
Does homeopathic Arnica Montana reduce bruising after blepharoplastyDoes homeopathic Arnica Montana reduce bruising after blepharoplasty
Does homeopathic Arnica Montana reduce bruising after blepharoplasty
 
Open Journal of Surgery
Open Journal of SurgeryOpen Journal of Surgery
Open Journal of Surgery
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Mdct2
Mdct2Mdct2
Mdct2
 
SISTEMA NERVIOSO
SISTEMA NERVIOSOSISTEMA NERVIOSO
SISTEMA NERVIOSO
 
E pass scoring
E pass scoringE pass scoring
E pass scoring
 
Trauma scoring systems
Trauma scoring systemsTrauma scoring systems
Trauma scoring systems
 
Anemia e Insuficiencia cardiaca. Manuel Méndez Bailón. Hospital Infanta Leono...
Anemia e Insuficiencia cardiaca. Manuel Méndez Bailón. Hospital Infanta Leono...Anemia e Insuficiencia cardiaca. Manuel Méndez Bailón. Hospital Infanta Leono...
Anemia e Insuficiencia cardiaca. Manuel Méndez Bailón. Hospital Infanta Leono...
 

Viewers also liked

Viewers also liked (9)

Local Website Visitors Boost
Local Website Visitors BoostLocal Website Visitors Boost
Local Website Visitors Boost
 
diploma
diplomadiploma
diploma
 
Getting More From Your Personal Bible Study FINAL
Getting More From Your Personal Bible Study  FINALGetting More From Your Personal Bible Study  FINAL
Getting More From Your Personal Bible Study FINAL
 
Ka Band Block Up Converter
Ka Band Block Up ConverterKa Band Block Up Converter
Ka Band Block Up Converter
 
Cox Purtell Perks at Work
Cox Purtell Perks at WorkCox Purtell Perks at Work
Cox Purtell Perks at Work
 
Emerging markets - In praise of volatility
Emerging markets - In praise of volatilityEmerging markets - In praise of volatility
Emerging markets - In praise of volatility
 
Límites y límites laterales
Límites y límites lateralesLímites y límites laterales
Límites y límites laterales
 
Basma Work samples
Basma Work samplesBasma Work samples
Basma Work samples
 
Asian GPs Could Run Afoul of AIFMD in Europe
Asian GPs Could Run Afoul of AIFMD in EuropeAsian GPs Could Run Afoul of AIFMD in Europe
Asian GPs Could Run Afoul of AIFMD in Europe
 

Similar to ASC 2015 Searchable Abstracts

The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...semualkaira
 
Cedars-Sinai Publication
Cedars-Sinai PublicationCedars-Sinai Publication
Cedars-Sinai Publicationmtchin08
 
40621_2019_Article_217.pdf
40621_2019_Article_217.pdf40621_2019_Article_217.pdf
40621_2019_Article_217.pdfraka42
 
Increased risk of ischemic stroke associated with new onset atrial fibrillat...
 Increased risk of ischemic stroke associated with new onset atrial fibrillat... Increased risk of ischemic stroke associated with new onset atrial fibrillat...
Increased risk of ischemic stroke associated with new onset atrial fibrillat...Francisco Javier Martínez Hernandez
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...daranisaha
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...semualkaira
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...semualkaira
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...eshaasini
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...JohnJulie1
 
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...Kundan Singh
 
Comparison of clinical, radiological and outcome characteristics of ischemic ...
Comparison of clinical, radiological and outcome characteristics of ischemic ...Comparison of clinical, radiological and outcome characteristics of ischemic ...
Comparison of clinical, radiological and outcome characteristics of ischemic ...MIMS Hospital
 
Blood transfusions 2016
Blood transfusions 2016Blood transfusions 2016
Blood transfusions 2016Vanessa Cruz
 
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...European School of Oncology
 
EGSYS_score_for_the_prediction_in_cardiac_etiology.pdf
EGSYS_score_for_the_prediction_in_cardiac_etiology.pdfEGSYS_score_for_the_prediction_in_cardiac_etiology.pdf
EGSYS_score_for_the_prediction_in_cardiac_etiology.pdfdavidsanchez321177
 
Vasc Med-2016-Hale-1358863X15624025
Vasc Med-2016-Hale-1358863X15624025Vasc Med-2016-Hale-1358863X15624025
Vasc Med-2016-Hale-1358863X15624025Kayla Twomey
 
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...Cardiovascular Diagnosis and Therapy (CDT)
 
Right Anterior Thoracotomy Minimally Invasive Aortic Valve Replacement vs. Co...
Right Anterior Thoracotomy Minimally Invasive Aortic Valve Replacement vs. Co...Right Anterior Thoracotomy Minimally Invasive Aortic Valve Replacement vs. Co...
Right Anterior Thoracotomy Minimally Invasive Aortic Valve Replacement vs. Co...semualkaira
 

Similar to ASC 2015 Searchable Abstracts (20)

Kwon et.al
Kwon et.alKwon et.al
Kwon et.al
 
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
 
Cedars-Sinai Publication
Cedars-Sinai PublicationCedars-Sinai Publication
Cedars-Sinai Publication
 
40621_2019_Article_217.pdf
40621_2019_Article_217.pdf40621_2019_Article_217.pdf
40621_2019_Article_217.pdf
 
Increased risk of ischemic stroke associated with new onset atrial fibrillat...
 Increased risk of ischemic stroke associated with new onset atrial fibrillat... Increased risk of ischemic stroke associated with new onset atrial fibrillat...
Increased risk of ischemic stroke associated with new onset atrial fibrillat...
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
 
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
 
GCS.PDF
GCS.PDFGCS.PDF
GCS.PDF
 
Comparison of clinical, radiological and outcome characteristics of ischemic ...
Comparison of clinical, radiological and outcome characteristics of ischemic ...Comparison of clinical, radiological and outcome characteristics of ischemic ...
Comparison of clinical, radiological and outcome characteristics of ischemic ...
 
Blood transfusions 2016
Blood transfusions 2016Blood transfusions 2016
Blood transfusions 2016
 
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
 
Crash score in tbi
Crash score in tbiCrash score in tbi
Crash score in tbi
 
EGSYS_score_for_the_prediction_in_cardiac_etiology.pdf
EGSYS_score_for_the_prediction_in_cardiac_etiology.pdfEGSYS_score_for_the_prediction_in_cardiac_etiology.pdf
EGSYS_score_for_the_prediction_in_cardiac_etiology.pdf
 
Vasc Med-2016-Hale-1358863X15624025
Vasc Med-2016-Hale-1358863X15624025Vasc Med-2016-Hale-1358863X15624025
Vasc Med-2016-Hale-1358863X15624025
 
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
 
Right Anterior Thoracotomy Minimally Invasive Aortic Valve Replacement vs. Co...
Right Anterior Thoracotomy Minimally Invasive Aortic Valve Replacement vs. Co...Right Anterior Thoracotomy Minimally Invasive Aortic Valve Replacement vs. Co...
Right Anterior Thoracotomy Minimally Invasive Aortic Valve Replacement vs. Co...
 

ASC 2015 Searchable Abstracts

  • 1. asc-abstracts.org http://www.asc-abstracts.org/ ASC 2015 Searchable Abstracts 9.01 Improving Predictive Value of Trauma Scoring Through Integration of ASA-PS with ISS D. Stewart1, C. Janowak1, H. Jung1, A. Liepert1, A. O’Rourke1, S. Agarwal1 1University Of Wisconsin,Surgery,Madison, WI, USA Introduction: Many methods exist for predicting mortality among adult trauma patients; however, most systems ignore patient co-morbidity, a significant predictor of outcome, in their calculations. The American Society of Anesthesiologists Physical Status (ASA-PS), a well-validated and easy-to-use scale, is an assessment of pre- operative status that has been shown to accurately predict post-operative mortality. Using the ASA-PS as a marker of cumulative patient comorbidity severity we sought to test whether we would be able to improve the predictive power of the Injury Severity Score (ISS), the most commonly utilized trauma grading system, with respect to mortality, major complication, and discharge disposition. Methods: A retrospective review of a prospectively collected and internally validated database at an academic Level I trauma center was performed for consecutive adult admissions between 2009-2013. Abbreviated Injury Scale (AIS) was measured by region (head/neck, face, thorax, abdomen, extremities, general) and severity of injury (1 to 5). ISS was measured by summing the squares of the three most injured regions [(AIS1)2 + (AIS2)2 + (AIS3)2]. ASA-PS scores were assigned based on patient comorbidities and then integrated with the traditional ISS in a variety of permutations, including adjustments of ASA-PS for patient age >70 and using individual AIS components of ISS. We assessed these various models for predictive ability with a primary outcome of mortality and secondary outcomes of major complications as per National Trauma Data Bank (NTDB) definitions as well as discharge disposition using receiver operating characteristic (ROC) analysis. These were compared with the ISS. Results: All of the ISS/ASA-PS hybrid formulas outperformed ISS alone in predictive power for mortality, major complication, and discharge disposition. The best overall permutation, (AIS1)2+(AIS2)2+(Age-Modified ASA-PS)2, yielded an ROC of 0.888 for mortality as compared to ISS with an ROC=0.853 (p<0.001). Similar differences were seen for discharge disposition (Hybrid ROC=0.743; ISS ROC=0.639, p<0.001) and major complication (Hybrid ROC=0.761; ISS ROC=0.719, p<0.001). Conclusion: Incorporating ASA-PS into calculations of trauma scoring is both simple and more predictive of mortality, major complication, and discharge disposition than the traditional ISS metric. Replacing ISS with this new method, which takes patient age and comorbid condition into account through adaptation of the ASA-PS improves prognostication of outcomes and enables care providers to prioritize resources for injured patients.
  • 2. Presentation Time: Tuesday, 7:30am - 9:30am 68.18 ASA-PS is Associated With Mortality Rate Among Adult Trauma Patients D. Stewart1, C. Janowak1, A. Liepert1, A. O’Rourke1, H. Jung1, S. Agarwal1 1University Of Wisconsin,Surgery,Madison, WI, USA Introduction: American Society of Anesthesiologists-Physical Status (ASA-PS) classification assesses pre- anesthesia surgical risk. Numerous studies correlate higher ASA-PS classification with increased perioperative mortality. As the number of comorbidities in a traumatically injured patient is correlated to mortality rate, we evaluated if ASA-PS was an indicator of mortality risk for adult trauma patients. Methods: Our prospectively collected and internally validated database at an academic Level I trauma center was retrospectively reviewed for adult patients for 2009-2013. ASA-PS scores were assigned based on patient comorbidities. Three different methods were used to reflect a lack of concordance on the consideration of patient age in establishing ASA-PS. In all three methods, NTDB-defined comorbidities were assigned an ASA-PS value and summed for each risk level. Patients with no comorbidities were considered PS1, while PS2 consisted of those with a single PS2 condition. Multiple PS2 conditions were considered multi-system disease, elevating a patient’s risk to PS3. Presence of 3+ PS3 conditions led to a PS4 classification. We then evaluated mortality rates as a primary outcome for each ASA-PS class using receiver operating characteristic (ROC) and Pearson Chi-Square analysis. Discharge disposition and major complications were assessed as secondary outcomes. Results: Model 1 (ASA), considered patient age >70 as a PS2 comorbidity, yielded an ROC of 0.619 for predicting mortality. Model 2, not including age as a factor in ASA-PS (ASA–w/o Age), produced an ROC of 0.615. Model 3, Age-Modified ASA (AM-ASA), produced an ROC of 0.648 (p<0.001). Cross-tabulation revealed mortality rates of
  • 3. 2.4%, 2.4%, 4%, and 13.2%, for PS1, PS2, PS3, and PS4, respectively. ASA–w/o Age (2.4%, 2.7%, 3.9%, and 13.2%) showed a similar trend, as did AM-ASA (2.4%, 1.9%, 2.9%, 10.2%), albeit with a dip in mortality rate for PS2. All three ASA models had two-sided p<0.001 under Pearson Chi-Square analysis of mortality rates. For discharge disposition (ASA ROC=0.668; ASA–w/o Age ROC=0.650; AM-ASA ROC=0.693) and major complications (ASA ROC=0.648; ASA–w/o Age ROC=0.653; AM-ASA ROC=0.641) all three models showed moderate predictive power. Conclusion: ASA-PS classification models show an association between higher risk status and increasing mortality rate. ASA-PS is moderately predictive of mortality, discharge disposition, and major complications per ROC analysis. AM-ASA performed significantly better for mortality and discharge disposition, indicating that age can serve as an adjustment to the codified system to improve accuracy in the trauma population. Presentation Time: Thursday, 1:30pm - 3:30pm 39.07 The Surgical Apgar Score in Major Esophageal Surgery C. F. Janowak2, L. Taylor2, J. Blasberg1, J. Maloney1, R. Macke1 1University Of Wisconsin,Division Of Cardiothoracic Surgery,Madison, WI, USA 2University Of Wisconsin,Department Of Surgery,Madison, WI, USA Introduction: Most postoperative assessments and triage decisions are based on subjective evaluation of a patient’s risk factors and overall condition. The Surgical Apgar Score (SAS) is a validated prognostic tool used to predict postoperative morbidity and mortality in a wide variety of surgical patients. The esophagectomy population is a unique subset of surgical patients who are high risk for post-operative complication and disposition resources. An objective prognostic metric is an appealing and efficient way to allocate limited care resources to the sickest of
  • 4. postoperative patients. Although other more complex risk calculators have been developed, the SAS is a simple, bedside usable, model that has been validated in a variety of surgical populations. We evaluated the reliability of the SAS in a major esophageal surgery population. Methods: A retrospective review of a prospectively collected and internally validated database of cardiothoracic operations was performed for consecutive esophagectomies from 2009 to 2013. Basic demographics, comorbidities, post-operative complications, and intraoperative variables were collected for all patients. The primary outcomes studied were mortality and NSQIP-defined in-hospital major complication; secondary outcomes were prolonged length of hospital stay (LOS) greater than 10 days and post-operative disposition. We used descriptive statistics, receiver operating characteristics (ROC) and Pearson Chi-Square analysis to analyze primary and secondary outcome prediction efficacy of SAS. Preoperative comorbid conditions were also analyzed for association with post-operative outcomes prognostication using odds ratio (OR) analysis. Results: A total of 172 consecutive esophageal resections over four years were reviewed. Overall mortality was 5 deaths (2.9%) with 4 occurring within 30 days of surgery, 1 after discharge within 30 days, and 1 after 90 days of hospitalization. Overall SAS 9-10, n=16; SAS 7-8, n=113; SAS 5-6, n= 42; and SAS ≤ 4, n=1. Of these, 34.3% had a major complication, 27.3% had a prolonged LOS, and 12.2% were discharged to a care facility other than home. No significant correlation was demonstrated between complication, LOS, or discharge disposition and the SAS with respective ROC of 0.44, 0.43, and 0.44. Of the preoperative comorbid conditions analyzed, only neoadjuvant chemoradiation significantly increased the risk of any outcome, with an OR of 3.59 (95% CI 1.38-9.37, p < 0.01) risk of discharge to care other than home. Conclusion: The perioperative performance measure of the SAS does not appear to have a good ability to predict major post-operative adverse outcomes in a major esophageal surgery population.